Healthcare has quietly become one of the most reliable paths to extraordinary wealth, producing hospital founders, drugmakers, and device innovators worth tens of billions each. This list breaks down ten of the most notable names, and later touches on how vendors use Medical and Healthcare Facilities Email lists to reach hospital decision-makers. Whether you’re researching the industry or just curious who’s behind the scenes, here’s what you should know about the people shaping modern healthcare.
Why Healthcare Produces So Many Billionaires
Healthcare is one of the few industries that touches nearly every person on the planet at some point, which creates enormous, durable demand for hospitals, medical devices, pharmaceuticals, and health technology. More than 260 billionaires on this year’s Forbes list built their fortunes in healthcare, spanning pharmaceuticals, medical devices, health tech, and life sciences investing. This represents a significant portion of the world’s wealthiest individuals and highlights the enormous amount of capital invested in hospital networks, pharmaceutical development, and medical supply chains each year.
According to Forbes’ 2026 World’s Billionaires List, 49 U.S. billionaires are associated with the healthcare industry. billionaires who built their fortunes in healthcare, a number that has grown steadily as the sector expands into digital health, biotech, and specialty pharmaceuticals. These fortunes are spread across a wide range of healthcare sectors rather than being limited to a single niche. They come from running massive hospital networks, inventing widely used surgical devices, developing blockbuster cancer drugs, and building the software that hospitals rely on to manage patient records.
What follows is a rundown of ten individuals whose wealth and influence make them worth knowing, whether you’re a patient, an investor, or simply someone interested in how healthcare fortunes get built.
Thomas Frist Jr. & Family
Thomas Frist Jr. consistently ranks as the wealthiest person in U.S. healthcare. Now 87, the former Air Force flight surgeon co-founded Hospital Corporation of America with his father back in 1968, building what would become one of the largest for-profit hospital operators in the country. HCA Healthcare today operates roughly 2,400 care sites nationwide, including hospitals, ambulatory surgery centers, freestanding emergency rooms, urgent care centers, and physician clinics.
Frist’s net worth has been estimated anywhere from roughly $31 billion to over $45 billion depending on the tracking source and time period, reflecting the volatility of holding a large ownership stake in a publicly traded healthcare company. He took HCA public for the third time in 2011 following two separate management buyouts, and he and his family continue to hold more than 25 percent of the company. Few names better illustrate how building essential healthcare infrastructure, rather than chasing trends, can generate enduring wealth across generations.
Larry Ellison
Larry Ellison is best known as the co-founder of Oracle, the software giant, but his healthcare footprint has grown substantially through the company’s expansion into health technology. He appears on lists of U.S. healthcare billionaires as chairman, chief technology officer, and co-founder of Oracle, a company that acquired electronic health records giant Cerner in a multibillion-dollar deal, pushing Oracle deep into hospital data systems and clinical software.
Ellison’s inclusion among healthcare billionaires highlights an important trend: technology and healthcare wealth are increasingly intertwined. As hospitals digitize records, adopt cloud infrastructure, and integrate AI into clinical workflows, software companies with a foothold in health systems are capturing a growing share of industry spending, and their founders are seeing that reflected in their net worth.
Patrick Soon-Shiong
Patrick Soon-Shiong is one of the rare individuals on this list who built his fortune through direct medical practice and drug innovation rather than corporate leadership alone. He is a physician and the inventor of the blockbuster cancer drug Abraxane, a treatment that has been used widely in oncology and helped establish his reputation as both a clinician and a biotech entrepreneur.
Soon-Shiong’s estimated net worth sits around $10.5 billion, built through a combination of pharmaceutical royalties, biotech ventures, and other business investments. He is among just a handful of physicians who have reached billionaire status through hospital systems, cancer drug innovation, or surgical patents, a distinction that sets him apart from healthcare billionaires who built wealth primarily through investment or corporate management rather than clinical practice.
Carl Cook
Carl Cook leads Cook Group, a major medical device manufacturer that produces a wide range of products used in cardiovascular, endoscopic, and other specialized procedures. As CEO of Cook Group, Carl Cook’s estimated net worth stands at roughly $11.7 billion, placing him solidly among the wealthiest figures in the U.S. medical device sector.
Cook Group has built its reputation over decades as a steady, privately held manufacturer rather than a flashy public company chasing headlines. That steady approach to device manufacturing, serving hospitals and surgical centers with reliable, specialized equipment, has proven to be a durable path to substantial wealth, even without the public profile of some other healthcare leaders on this list.
Robert Duggan
Robert Duggan has built his fortune through leadership roles in biotechnology and pharmaceutical development. He currently serves as co-CEO of Summit Therapeutics, with an estimated net worth of around $11.6 billion. Duggan’s career reflects a pattern common among healthcare billionaires: moving between multiple biotech ventures and capturing significant value through drug development and company leadership over an extended career.
Summit Therapeutics has drawn industry attention for its work in oncology treatments, and Duggan’s continued involvement in the sector demonstrates how experienced biotech executives can build substantial personal wealth by staying closely tied to drug development pipelines rather than stepping back after an initial success.
Charlie Mills
Charlie Mills chairs Medline, one of the largest privately held manufacturers and distributors of medical supplies in the United States. His estimated net worth is roughly $11.4 billion, built through Medline’s extensive reach across hospitals, nursing homes, home healthcare providers, and other medical facilities nationwide.
Medline’s business model, supplying the everyday products hospitals and clinics depend on constantly, from gloves and gowns to surgical instruments, has proven remarkably resilient. Unlike pharmaceutical or biotech companies, which can see dramatic swings tied to a single drug’s success or failure, medical supply distribution tends to generate steady, predictable revenue, which has helped build and preserve the Mills family’s wealth over time.
Ronda Stryker
Ronda Stryker is a director of Stryker Corporation, one of the most recognized names in the medical device industry, known for products used in orthopedics, surgical equipment, and neurotechnology. Her estimated net worth stands at approximately $8.5 billion, reflecting her family’s long-standing ownership stake in the company her grandfather founded.
Stryker Corporation has grown into a global medical device leader, and Ronda Stryker’s continued involvement as a director has kept her closely connected to the company’s strategic direction. Her presence on this list also highlights how healthcare fortunes are often generational, passed down and grown across family members who maintain active roles in the businesses their relatives built decades earlier.
John Brown
John Brown is the former chairman of Stryker Corporation, having led the company during a significant period of its growth into a major medical device manufacturer. His estimated net worth is also around $8.5 billion, placing him alongside Ronda Stryker among the wealthiest individuals connected to the company.
Brown’s tenure at Stryker helped establish the company as a dominant player in orthopedic implants and surgical technology, and his continued financial stake in the business reflects the long-term value created during his leadership. Like several others on this list, his wealth demonstrates how leading a well-run medical device company over a sustained period can generate enormous personal wealth alongside the company’s own growth.
Gary Michelson
Gary Michelson stands out on this list as a retired orthopedic and spinal surgeon rather than a corporate executive. He holds roughly 340 U.S. patents for surgical instruments, an extraordinary body of inventive work that has generated substantial licensing revenue over the course of his career.
Michelson’s path to billionaire status illustrates a different route into healthcare wealth: inventing widely used surgical tools and holding the patents that protect them. Rather than running a hospital system or a pharmaceutical company, his fortune stems directly from years of clinical practice combined with a prolific inventing career, showing that innovation at the surgical table itself can be just as lucrative as building a large healthcare business.
Sun Piaoyang
Rounding out this list with an international perspective, Sun Piaoyang represents the global reach of healthcare wealth beyond the United States. He serves as chairman of Jiangsu Hengrui Pharmaceuticals, a company that develops treatments for cancer and infectious diseases, and has built one of the most significant pharmaceutical fortunes in China.
Hengrui’s drugs have attracted strong interest from major global pharmaceutical companies, and the company struck a deal with GSK last year to develop a dozen drugs across multiple diseases, an agreement worth up to $12 billion. Sun Piaoyang’s inclusion here is a reminder that healthcare billionaires aren’t confined to any single country. As pharmaceutical innovation becomes increasingly global, fortunes built on drug development are emerging from research and manufacturing hubs well beyond the United States.
What These Billionaires Have in Common
Looking across this list, a few clear patterns emerge. First, healthcare wealth tends to be built over long careers rather than overnight success. Frist, Cook, Mills, and the Stryker-connected billionaires all built their fortunes through decades of steady leadership in hospital operations, device manufacturing, or medical supply distribution rather than a single breakthrough moment.
Second, innovation still matters enormously, whether that’s Soon-Shiong’s cancer drug, Michelson’s surgical patents, or Sun Piaoyang’s pharmaceutical pipeline. Patents, proprietary drugs, and specialized medical technology continue to be some of the most reliable paths to extraordinary wealth in this sector, since they create products hospitals and physicians can’t easily substitute or replicate.
Third, technology’s growing role in healthcare, illustrated by Larry Ellison’s involvement through Oracle’s health records business, shows that the traditional boundaries between “tech billionaire” and “healthcare billionaire” are increasingly blurry. As hospitals rely more heavily on cloud infrastructure, AI-assisted tools, and digital record systems, technology leaders are capturing a larger share of healthcare industry wealth than they might have a decade ago.
Finally, family involvement remains a defining feature of many healthcare fortunes. The Frist family, the Stryker family, and the Mills family at Medline all illustrate how healthcare businesses, once established, tend to stay within families for generations, with new members stepping into leadership or ownership roles that keep the original fortune growing.
Reaching Healthcare Decision-Makers: A Note for Marketers and Vendors
For companies selling medical equipment, pharmaceuticals, software, or professional services into the healthcare space, understanding who holds influence, whether that’s a billionaire founder, a hospital system executive, or a facility administrator, is only part of the picture. Reaching the right contacts at hospitals, clinics, and healthcare facilities requires accurate, well-organized outreach data.
This is where a carefully built Medical and Healthcare Facilities Mailing List becomes genuinely useful for vendors, healthcare technology companies, and service providers trying to connect with hospital administrators, procurement teams, and facility decision-makers. A strong list should be segmented by facility type (hospitals, ambulatory surgery centers, long-term care facilities, physician clinics), size, and geographic region, since purchasing processes and decision-making authority can vary significantly across these categories.
Companies pursuing this kind of outreach should prioritize accuracy and relevance over sheer volume. Healthcare administrators and procurement teams receive a constant stream of vendor communication, so messaging that’s clearly targeted, respects professional norms, and complies with applicable email marketing regulations tends to perform far better than broad, generic campaigns. Building trust with this audience over time matters more than any single email blast, especially in an industry where relationships and reputation carry substantial weight in purchasing decisions.
Final Thoughts on Healthcare’s Wealthiest Figures
The individuals on this list represent very different paths into extraordinary wealth: hospital operators, device manufacturers, pharmaceutical innovators, surgeons-turned-inventors, and even a software executive whose company has become deeply embedded in hospital record-keeping. What ties them together is a shared connection to an industry that touches virtually everyone, and one that continues to grow as populations age, chronic disease rates rise, and medical technology advances.
For consumers and industry observers alike, understanding who these figures are, and how they built their fortunes, offers a useful window into where healthcare’s biggest opportunities and largest revenue streams actually lie. Whether through hospital operations, surgical innovation, or pharmaceutical development, the paths to billionaire status in healthcare remain varied, but consistently tied to solving real, large-scale problems in patient care.
Conclusion
Healthcare Industry Billionaires like Thomas Frist Jr., Patrick Soon-Shiong, and Gary Michelson show just how varied the paths to extraordinary wealth in this sector can be, from hospital operations and surgical patents to pharmaceutical innovation and health technology. Their stories reflect decades of steady growth rather than overnight success, built on solving real problems in patient care and medical infrastructure.
For companies aiming to reach hospitals, clinics, and facility administrators, a well-organized Medical and Healthcare Facilities Mailing list remains one of the most effective ways to connect with the right decision-makers. As the healthcare industry keeps expanding, both its billionaires and the professionals managing its facilities will continue shaping how care gets delivered nationwide.
